Drug profile · INN
benzonatate
BENZONATATE
benzonatate (BENZONATATE) is a slowly adapting pulmonary stretch receptor inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — benzonatate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
benzonatate (BENZONATATE) is a slowly adapting pulmonary stretch receptor inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Slowly adapting pulmonary stretch receptor inhibitor
Primary target: Slowly adapting pulmonary stretch receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is benzonatate?
benzonatate (BENZONATATE) is a slowly adapting pulmonary stretch receptor inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for benzonatate?
BENZONATATE is a marketed brand name for benzonatate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of benzonatate?
benzonatate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.